Info Sheets , Formulation Development

Quotient Sciences Drug Product Formulation Development Info Sheet

Overview

We work with you to develop the most appropriate drug product formulation to meet your phase of development.

Our innovative approach to drug product formulation development is based on our proven track record in early clinical evaluation, delivering phase-appropriate formulations across the product development pathway from preclinical to late-stage. 

With expertise in formulation development to meet the needs of both simple and complex dosage forms, our approach has been validated through our work with over 1,500 molecules at all stages of development.

How our formulation development services can help

Contact us today to learn how we can help:

Download
Ask The Experts

Drug product formulation questions? Get answers from our team.

Have a question about your drug product formulation? Ask a member of our team about our capabilities for formulation development, solubility enhancement, and more.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
John McDermott

VP, Scientific Consulting

John McDermott leads Quotient Sciences' global drug development consulting, research fellows, modeling & simulation, and clien...

About John
Dr. Helen Baker

Director, Formulation Design

Dr. Helen Baker has over 15 years of formulation and product development experience within the pharmaceutical, biotech, and agrono...

About Helen
Let's Talk
Humanity can't wait, so neither can we. Discuss your drug program today.